InflaRx had been pursuing development of vilobelimab in other indications beyond COVID, but the company’s hopes for the asset ...
InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...
ABSTRACT: Pyoderma Gangrenosum (PG) is an autoinflammatory condition mimicking Surgical Site Infection in the postoperative period and both these conditions differ entirely in terms of their ...
ABSTRACT: Pyoderma Gangrenosum (PG) is an autoinflammatory condition mimicking Surgical Site Infection in the postoperative period and both these conditions differ entirely in terms of their ...
No Name Club were among the many groups to pay tribute to Edith Geraghty from Belmullet who passed away following an illness ...
Crohn's disease and some of its treatments can cause skin issues like rashes and lesions. Erythema nodosum is common with Crohn's and appears as tender red bumps on the legs. Crohn's can also affect ...
Aside from the layoffs, InflaRx will deprioritize Gohibic, a COVID-19 antibody that was granted emergency use authorization ...
Then InflaRx presented a new analysis of vilobelimab for pyoderma gangrenosum, and Pfizer disclosed a death in a long term Hympavzi study after thrombotic stroke. Also of note, after previous setbacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback